To confirm whether the impact of MYC inhibition was conserved across different genetic backgrounds and breast cancer subtypes, our panel of cell lines was seeded at low density and treated for periods of 2 to 7 weeks (depending on their proliferation rate), and then stained with crystal violet. This evidence concerns the gene MYC and breast carcinoma.